Stoli Catalysts designs and manufactures continuous flow processes that dramatically cut the manufacturing cost of fine and speciality chemicals such as fragrances, food supplements, cosmetics and intermediates for pharmaceuticals.
Stoli’s core technology is based on fixing catalysts to the inside walls of reactor tubing and other channel-based geometries and passing the multiphase gas and liquid components over the surfaces. In contrast, traditional batch processing mixes powdered catalysts in a pot with the other ingredients. Using continuous flow processing, StoliFlowTM systems are much more efficient than traditional batch processes and readily scalable. Production efficiencies in energy, labour, reaction time and waste deliver significant cost reductions and margin enhancement, as well as lower environmental impact. It has two patent applications at international stage.
Stoli is targeting the $600bn fine chemicals market that includes perfumes, cosmetics, nutraceuticals and ingredients used to make pharmaceuticals. The near-term addressable market for StoliFlowTM products, system designs and services is approximately $800m. Its aim is to be the leader in sustainable, low-impact catalytic and enzymatic continuous flow production of fine and specialty chemicals. Longer-term target markets in enzymatic biosynthesis and biofuels are valued at over $2bn.
Stoli is developing a system design and licensing model with the first commercial-scale pilot plant to be delivered in H2.21. Additionally, it provides services in process and catalyst development, catalyst coatings, characterisation and proof-of-concept projects as a means to developing customer relationships. Sales to date are over £200,000. Customers include Airbus, Adisseo and SABIC.